Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Powell

Showing results (451-460 of 493) with videos related to

Pageof 50
Sort By:
Plos Medicine|June 17, 2015
Associations between Potentially Modifiable Risk Factors and Alzheimer Disease: A Mendelian Randomization StudySøren D Østergaard, Shubhabrata Mukherjee, Stephen J Sharp, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 18, 2020
Long-Term Overall Survival From KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin With or Without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous NSCLCMark M Awad, Shirish M Gadgeel, Hossein Borghaei, et al.
Journal of Virology|April 10, 1999
High-level variability in the ORF-K1 membrane protein gene at the left end of the Kaposi's sarcoma-associated herpesvirus genome defines four major virus subtypes and multiple variants or clades in different human populationsJ C Zong, D M Ciufo, D J Alcendor, et al.
Molecular Psychiatry|September 14, 1999
Autosome search for schizophrenia susceptibility genes in multiply affected familiesM I Rees, I Fenton, N M Williams, et al.
Neurobiology of Aging|June 2, 2014
Exome sequencing identifies 2 novel presenilin 1 mutations (p.L166V and p.S230R) in British early-onset Alzheimer's diseaseCeleste Sassi, Rita Guerreiro, Raphael Gibbs, et al.
Investigational New Drugs|March 21, 2022
Phase II study of dichloroacetate, an inhibitor of pyruvate dehydrogenase, in combination with chemoradiotherapy for unresected, locally advanced head and neck squamous cell carcinomaSteven F Powell, Miroslaw Mazurczak, Elie G Dib, et al.
ESMO Open|May 22, 2025
Phase II study of elraglusib (9-ING-41), a GSK-3β inhibitor, in combination with gemcitabine plus nab-paclitaxel in previously untreated metastatic pancreatic cancerD Mahalingam, A Saeed, S F Powell, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 2, 2016
Rare genetic variation in UNC13A may modify survival in amyotrophic lateral sclerosisBenjamin Gaastra, Aleksey Shatunov, Sara Pulit, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2025
Phase 1 and 2 Clinical Studies of the STING Agonist Ulevostinag With and Without Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors or LymphomasKevin J Harrington, Stephane Champiat, Joshua D Brody, et al.
The Plant Journal : for Cell and Molecular Biology|November 13, 2019
PEATmoss (Physcomitrella Expression Atlas Tool): a unified gene expression atlas for the model plant Physcomitrella patensNoe Fernandez-Pozo, Fabian B Haas, Rabea Meyberg, et al.
Pageof 50

Showing results (451-460 of 493) with videos related to

Sort By:
Pageof 50
Plos Medicine|June 17, 2015
Associations between Potentially Modifiable Risk Factors and Alzheimer Disease: A Mendelian Randomization StudySøren D Østergaard, Shubhabrata Mukherjee, Stephen J Sharp, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 18, 2020
Long-Term Overall Survival From KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin With or Without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous NSCLCMark M Awad, Shirish M Gadgeel, Hossein Borghaei, et al.
Journal of Virology|April 10, 1999
High-level variability in the ORF-K1 membrane protein gene at the left end of the Kaposi's sarcoma-associated herpesvirus genome defines four major virus subtypes and multiple variants or clades in different human populationsJ C Zong, D M Ciufo, D J Alcendor, et al.
Molecular Psychiatry|September 14, 1999
Autosome search for schizophrenia susceptibility genes in multiply affected familiesM I Rees, I Fenton, N M Williams, et al.
Neurobiology of Aging|June 2, 2014
Exome sequencing identifies 2 novel presenilin 1 mutations (p.L166V and p.S230R) in British early-onset Alzheimer's diseaseCeleste Sassi, Rita Guerreiro, Raphael Gibbs, et al.
Investigational New Drugs|March 21, 2022
Phase II study of dichloroacetate, an inhibitor of pyruvate dehydrogenase, in combination with chemoradiotherapy for unresected, locally advanced head and neck squamous cell carcinomaSteven F Powell, Miroslaw Mazurczak, Elie G Dib, et al.
ESMO Open|May 22, 2025
Phase II study of elraglusib (9-ING-41), a GSK-3β inhibitor, in combination with gemcitabine plus nab-paclitaxel in previously untreated metastatic pancreatic cancerD Mahalingam, A Saeed, S F Powell, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 2, 2016
Rare genetic variation in UNC13A may modify survival in amyotrophic lateral sclerosisBenjamin Gaastra, Aleksey Shatunov, Sara Pulit, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2025
Phase 1 and 2 Clinical Studies of the STING Agonist Ulevostinag With and Without Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors or LymphomasKevin J Harrington, Stephane Champiat, Joshua D Brody, et al.
The Plant Journal : for Cell and Molecular Biology|November 13, 2019
PEATmoss (Physcomitrella Expression Atlas Tool): a unified gene expression atlas for the model plant Physcomitrella patensNoe Fernandez-Pozo, Fabian B Haas, Rabea Meyberg, et al.
Pageof 50